Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases

NCT01988506 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis
Ankylosing Spondylitis
Systemic Lupus Erythematosus
Psoriasis
Behcet's Disease
Wegener's Granulomatosis
Takayasu's Disease
Crohn's Disease
Ulcerative Colitis
Autoimmune Hepatitis
Sclerosing Cholangitis
Gougerot-sjögren
Idiopathic Thrombocytopenic Purpura
Systemic Sclerosis

Interventions

DRUG: Interleukin 2

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]